Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Andrieu

Showing results (161-170 of 173) with videos related to

Pageof 18
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 26, 1998
Cell cycle phase-specific surface expression of nerve growth factor receptors TrkA and p75(NTR)J L Urdiales, E Becker, M Andrieu, et al.
Bulletin Du Cancer|January 1, 1993
[Hodgkin disease, clinical stages IA-IIB: evaluation of the value of cisplatin. Preliminary results]M Belhani, M I Belkaïd, R Ahmed-Naceur, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 3, 1999
New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDSH Hendel, S Caillat-Zucman, H Lebuanec, et al.
Journal of Viral Hepatitis|June 24, 2006
Interferon gamma-secreting HCV-specific CD8+ T cells in the liver of patients with chronic C hepatitis: relation to liver fibrosis--ANRS HC EP07 studyN Bonilla, N Barget, M Andrieu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Mediastinal tumor size and response to chemotherapy are the only prognostic factors in supradiaphragmatic Hodgkin's disease treated by ABVD plus radiotherapy: ten-year results of the Paris-Ouest-France 81/12 trial, including 262 patientsP Colonna, J P Jais, B Desablens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1998
Ten-year results of a strategy combining three cycles of ABVD and high-dose extended irradiation for treating Hodgkin's disease at advanced stagesJ M Andrieu, J P Jais, P Colonna, et al.
Journal of Dental Research|December 8, 2021
Oral Condition and Incident Coronary Heart Disease: A Clustering AnalysisO Deraz, H Rangé, P Boutouyrie, et al.
Bulletin Du Cancer|April 1, 1997
[Subcutaneous administration of interleukin-2 in ambulatory treatment of patients with metastatic renal cancer. Three-year results of the SCAPP I program]J M Tourani, C Jaillon-Abraham, V Lucas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1996
Subcutaneous recombinant interleukin-2 (rIL-2) in out-patients with metastatic renal cell carcinoma. Results of a multicenter SCAPP1 trialJ M Tourani, V Lucas, D Mayeur, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 2, 1998
Distinctive effects of CCR5, CCR2, and SDF1 genetic polymorphisms in AIDS progressionH Hendel, N Hénon, H Lebuanec, et al.
Pageof 18

Showing results (161-170 of 173) with videos related to

Sort By:
Pageof 18
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 26, 1998
Cell cycle phase-specific surface expression of nerve growth factor receptors TrkA and p75(NTR)J L Urdiales, E Becker, M Andrieu, et al.
Bulletin Du Cancer|January 1, 1993
[Hodgkin disease, clinical stages IA-IIB: evaluation of the value of cisplatin. Preliminary results]M Belhani, M I Belkaïd, R Ahmed-Naceur, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 3, 1999
New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDSH Hendel, S Caillat-Zucman, H Lebuanec, et al.
Journal of Viral Hepatitis|June 24, 2006
Interferon gamma-secreting HCV-specific CD8+ T cells in the liver of patients with chronic C hepatitis: relation to liver fibrosis--ANRS HC EP07 studyN Bonilla, N Barget, M Andrieu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Mediastinal tumor size and response to chemotherapy are the only prognostic factors in supradiaphragmatic Hodgkin's disease treated by ABVD plus radiotherapy: ten-year results of the Paris-Ouest-France 81/12 trial, including 262 patientsP Colonna, J P Jais, B Desablens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1998
Ten-year results of a strategy combining three cycles of ABVD and high-dose extended irradiation for treating Hodgkin's disease at advanced stagesJ M Andrieu, J P Jais, P Colonna, et al.
Journal of Dental Research|December 8, 2021
Oral Condition and Incident Coronary Heart Disease: A Clustering AnalysisO Deraz, H Rangé, P Boutouyrie, et al.
Bulletin Du Cancer|April 1, 1997
[Subcutaneous administration of interleukin-2 in ambulatory treatment of patients with metastatic renal cancer. Three-year results of the SCAPP I program]J M Tourani, C Jaillon-Abraham, V Lucas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1996
Subcutaneous recombinant interleukin-2 (rIL-2) in out-patients with metastatic renal cell carcinoma. Results of a multicenter SCAPP1 trialJ M Tourani, V Lucas, D Mayeur, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 2, 1998
Distinctive effects of CCR5, CCR2, and SDF1 genetic polymorphisms in AIDS progressionH Hendel, N Hénon, H Lebuanec, et al.
Pageof 18